The AVMA recognizes the importance of NARMS as a valuable resource for information on resistance monitoring of bacterial isolates from animals, animal products, and humans. Therefore, the AVMA recommends that the USDA, FDA, and CDC budget for adequate and equitable funding of the resistance monitoring system and for the timely reporting of results in order to be able to provide a current and relevant resource regarding new information for bacterial resistance patterns.